Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

References 

1. Hughes DE, Wright KR, Uy HL, et al.  Bisphosphonates promotes apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995;10:1478
   • MEDLINE
   • CrossRef
2. Vitte C, Fleisch H, Guenthes HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclastic mediated resorption. Endocrinology. 1996;137:2324
   • MEDLINE
   • CrossRef
3. Hughes DE, MacDonald BR, Russell RG, et al.  Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest. 1989;83:1930
   • MEDLINE
   • CrossRef
4. Sato M, Grasser W. Effects of bisphosphonates on isolated cat osteoclast as examined by reflected light microscopy. J Bone Miner Res. 1990;5:31
   • MEDLINE
   • CrossRef
5. Teronen O, Heikkila P, Konttinenn YT, et al.  MMP inhibition and down regulation by bisphosphonates. Ann NY Acad Sci. 1999;878:453
6. Schenk RK. Bone regeneration (Biologic basis). In:  Buser D,  Dahlin C,  Schenk RK, et al. editor. Guided Bone Regeneration in Implant Dentistry. Chicago, IL: Quintessence; 1994;p. 49–100
7. Parfett AM. Osteonal and hemiosteonal remodeling, The spatial and temporal framework for signal traffic in adult human bone. J Cellular Biochem. 1994;55:273
8. Frith JC, Monkkonen J, Blackburn GM, et al.  Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosire 5”-(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res. 1997;12:1358
   • MEDLINE
   • CrossRef
9. Tenenbaum HC, Shelemay A, Girard B, et al.  Bisphosphonates and periodontics (potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses). J Periodontol. 2002;73:813
   • MEDLINE
   • CrossRef
10. Fleisch H. In: Bisphosphonates in Bone Disease (From the Laboratory to the Patient). San Diego, CA: Academic Press; 2000;p. 34–55